153 related articles for article (PubMed ID: 38243248)
1. Selective SERCA2a activator as a candidate for chronic heart failure therapy.
Arici M; Hsu SC; Ferrandi M; Barassi P; Ronchi C; Torre E; Luraghi A; Chang GJ; Ferrari P; Bianchi G; Peri F; Zaza A; Rocchetti M
J Transl Med; 2024 Jan; 22(1):77. PubMed ID: 38243248
[TBL] [Abstract][Full Text] [Related]
2. Istaroxime Metabolite PST3093 Selectively Stimulates SERCA2a and Reverses Disease-Induced Changes in Cardiac Function.
Arici M; Ferrandi M; Barassi P; Hsu SC; Torre E; Luraghi A; Ronchi C; Chang GJ; Peri F; Ferrari P; Bianchi G; Rocchetti M; Zaza A
J Pharmacol Exp Ther; 2023 Jan; 384(1):231-244. PubMed ID: 36153005
[TBL] [Abstract][Full Text] [Related]
3. Highly Selective SERCA2a Activators: Preclinical Development of a Congeneric Group of First-in-Class Drug Leads against Heart Failure.
Luraghi A; Ferrandi M; Barassi P; Arici M; Hsu SC; Torre E; Ronchi C; Romerio A; Chang GJ; Ferrari P; Bianchi G; Zaza A; Rocchetti M; Peri F
J Med Chem; 2022 May; 65(10):7324-7333. PubMed ID: 35580334
[TBL] [Abstract][Full Text] [Related]
4. Istaroxime stimulates SERCA2a and accelerates calcium cycling in heart failure by relieving phospholamban inhibition.
Ferrandi M; Barassi P; Tadini-Buoninsegni F; Bartolommei G; Molinari I; Tripodi MG; Reina C; Moncelli MR; Bianchi G; Ferrari P
Br J Pharmacol; 2013 Aug; 169(8):1849-61. PubMed ID: 23763364
[TBL] [Abstract][Full Text] [Related]
5. SERCA2a stimulation by istaroxime improves intracellular Ca2+ handling and diastolic dysfunction in a model of diabetic cardiomyopathy.
Torre E; Arici M; Lodrini AM; Ferrandi M; Barassi P; Hsu SC; Chang GJ; Boz E; Sala E; Vagni S; Altomare C; Mostacciuolo G; Bussadori C; Ferrari P; Bianchi G; Rocchetti M
Cardiovasc Res; 2022 Mar; 118(4):1020-1032. PubMed ID: 33792692
[TBL] [Abstract][Full Text] [Related]
6. Istaroxime, a stimulator of sarcoplasmic reticulum calcium adenosine triphosphatase isoform 2a activity, as a novel therapeutic approach to heart failure.
Micheletti R; Palazzo F; Barassi P; Giacalone G; Ferrandi M; Schiavone A; Moro B; Parodi O; Ferrari P; Bianchi G
Am J Cardiol; 2007 Jan; 99(2A):24A-32A. PubMed ID: 17239701
[TBL] [Abstract][Full Text] [Related]
7. Targeting SERCA2a as an innovative approach to the therapy of congestive heart failure.
Ferrari P; Micheletti R; Valentini G; Bianchi G
Med Hypotheses; 2007; 68(5):1120-5. PubMed ID: 17113239
[TBL] [Abstract][Full Text] [Related]
8. SERCA2a stimulation by istaroxime: a novel mechanism of action with translational implications.
Huang CL
Br J Pharmacol; 2013 Oct; 170(3):486-8. PubMed ID: 23822610
[TBL] [Abstract][Full Text] [Related]
9. Combining SERCA2a activation and Na-K ATPase inhibition: a promising new approach to managing acute heart failure syndromes with low cardiac output.
Gheorghiade M; Ambrosy AP; Ferrandi M; Ferrari P
Discov Med; 2011 Aug; 12(63):141-51. PubMed ID: 21878191
[TBL] [Abstract][Full Text] [Related]
10. SERCA2a gene transfer decreases sarcoplasmic reticulum calcium leak and reduces ventricular arrhythmias in a model of chronic heart failure.
Lyon AR; Bannister ML; Collins T; Pearce E; Sepehripour AH; Dubb SS; Garcia E; O'Gara P; Liang L; Kohlbrenner E; Hajjar RJ; Peters NS; Poole-Wilson PA; Macleod KT; Harding SE
Circ Arrhythm Electrophysiol; 2011 Jun; 4(3):362-72. PubMed ID: 21406682
[TBL] [Abstract][Full Text] [Related]
11. Targeted sarcoplasmic reticulum Ca2+ ATPase 2a gene delivery to restore electrical stability in the failing heart.
Cutler MJ; Wan X; Plummer BN; Liu H; Deschenes I; Laurita KR; Hajjar RJ; Rosenbaum DS
Circulation; 2012 Oct; 126(17):2095-104. PubMed ID: 23019291
[TBL] [Abstract][Full Text] [Related]
12. Modulation of sarcoplasmic reticulum function by PST2744 [istaroxime; (E,Z)-3-((2-aminoethoxy)imino) androstane-6,17-dione hydrochloride)] in a pressure-overload heart failure model.
Rocchetti M; Alemanni M; Mostacciuolo G; Barassi P; Altomare C; Chisci R; Micheletti R; Ferrari P; Zaza A
J Pharmacol Exp Ther; 2008 Sep; 326(3):957-65. PubMed ID: 18539651
[TBL] [Abstract][Full Text] [Related]
13. A pyridone derivative activates SERCA2a by attenuating the inhibitory effect of phospholamban.
Kaneko M; Yamamoto H; Sakai H; Kamada Y; Tanaka T; Fujiwara S; Yamamoto S; Takahagi H; Igawa H; Kasai S; Noda M; Inui M; Nishimoto T
Eur J Pharmacol; 2017 Nov; 814():1-8. PubMed ID: 28734932
[TBL] [Abstract][Full Text] [Related]
14. New N-aryl-N-alkyl-thiophene-2-carboxamide compound enhances intracellular Ca
Nikolaienko R; Bovo E; Yuen SL; Treinen LM; Berg K; Aldrich CC; Thomas DD; Cornea RL; Zima AV
Biophys J; 2023 Jan; 122(2):386-396. PubMed ID: 36463408
[TBL] [Abstract][Full Text] [Related]
15.
Wu T; Yao H; Zhang B; Zhou S; Hou P; Chen K
Oxid Med Cell Longev; 2021; 2021():7328437. PubMed ID: 34373768
[TBL] [Abstract][Full Text] [Related]
16. Rg3 promotes the SUMOylation of SERCA2a and corrects cardiac dysfunction in heart failure.
Liu Z; Bian X; Gao W; Su J; Ma C; Xiao X; Yu T; Zhang H; Liu X; Fan G
Pharmacol Res; 2021 Oct; 172():105843. PubMed ID: 34428586
[TBL] [Abstract][Full Text] [Related]
17. Cellular Mechanisms Underlying the Low Cardiotoxicity of Istaroxime.
Racioppi MF; Burgos JI; Morell M; Gonano LA; Vila Petroff M
J Am Heart Assoc; 2021 Jul; 10(14):e018833. PubMed ID: 34219467
[TBL] [Abstract][Full Text] [Related]
18. Modulation of sarcoplasmic reticulum function by Na+/K+ pump inhibitors with different toxicity: digoxin and PST2744 [(E,Z)-3-((2-aminoethoxy)imino)androstane-6,17-dione hydrochloride].
Rocchetti M; Besana A; Mostacciuolo G; Micheletti R; Ferrari P; Sarkozi S; Szegedi C; Jona I; Zaza A
J Pharmacol Exp Ther; 2005 Apr; 313(1):207-15. PubMed ID: 15576469
[TBL] [Abstract][Full Text] [Related]
19. CYP2J2-derived epoxyeicosatrienoic acids suppress endoplasmic reticulum stress in heart failure.
Wang X; Ni L; Yang L; Duan Q; Chen C; Edin ML; Zeldin DC; Wang DW
Mol Pharmacol; 2014 Jan; 85(1):105-15. PubMed ID: 24145329
[TBL] [Abstract][Full Text] [Related]
20. Regulation of cardiac calcium signaling by newly identified calcium pump modulators.
Bovo E; Rebbeck RT; Roopnarine O; Cornea RL; Thomas DD; Zima AV
Biochem Biophys Res Commun; 2023 Dec; 685():149136. PubMed ID: 37907012
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
